OMass Therapeutics secures €273M Series C

UK biotech OMass Therapeutics closed a €273M Series C round dated 16 October 2026, ranking among the larger non-debt rounds in the UK over the past 30 days.

AI-generatedWritten by an AI model from Tech.eu Funding Explorer data (2026-10-21). Figures are checked against the underlying data and each draft is reviewed by an independent second model before publishing; anything unverifiable is held back. Not investment advice. Labelled for AI transparency (EU AI Act Art. 50, applicable from 2 Aug 2026).